Profound Medical expects Q3 revenue of USD 9.8 million-USD 10 million

PROF•2026-10-07

Profound Medical forecast preliminary Q3 2026 revenue of USD 9.8 million to USD 10 million, 45% to 47% above consensus. It expects gross margin to exceed 70%.

1. Preliminary Q3 outlook

Profound Medical forecast preliminary Q3 2026 revenue of USD 9.8 million to USD 10 million, up 85% to 89% from USD 5.3 million in Q3 2025 and 292% to 300% from USD 2.5 million in Q2 2026. The forecast is 45% to 47% above mean consensus of USD 6.78 million, and the company expects gross margin to exceed 70%.

Profound Medical expects Q3 revenue of USD 9.8 million-USD 10 million

1. Preliminary Q3 outlook

Related News

APA forecasts 3Q average realized US oil price at $87.50 per bbl, international at $98.50 per bbl

Ohmyhome signs standby equity purchase agreement for up to $40 million in share sales

Patterson-UTI Energy schedules third-quarter earnings call and webcast

Scorpio Tankers appoints Charlotte Wheatcroft as company secretary

Stoneridge names Vivek Anand VP, commercial strategy and global sales